Evidence map›Paper›PMID 42153926›Full record

ArticleJACC. Case reports2026

Imaging of Myocardial Carcinoid Metastasis.

Shreyas Ranganath, Leslie Ynalvez, Hyeon-Ju Ryoo Ali, Ihab Hamzeh, Salil Kumar, Carl Zehner, Efstratios Koutroumpakis, Nicolas Palaskas, Chandrikha Chandrasekharan, Anita Deswal and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shreyas RanganathMcGovern Medical School at the UTHealth, Houston, Texas, USA.
Leslie YnalvezUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Hyeon-Ju Ryoo AliUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Ihab HamzehUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Salil KumarUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Carl ZehnerUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Efstratios KoutroumpakisUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Nicolas PalaskasUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Chandrikha ChandrasekharanUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Anita DeswalUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Cezar IliescuUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA.
Shaden KhalafUniversity of Texas MD Anderson Cancer Center, Austin, Texas, USA. Electronic address: szkhalaf@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumors (NETs) are indolent neoplasms that may metastasize to the heart, though myocardial involvement is under-recognized and often asymptomatic. We present a case series of 2 patients with metastatic NETs and isolated cardiac metastases without valvular involvement, highlighting the role of multimodality imaging. In both cases, cardiac metastases were initially identified on Gallium-68 DOTATATE positron emission tomography/computed tomography and further characterized by cardiac magnetic resonance (CMR), while transthoracic echocardiography had limited ability to identify myocardial metastases. One patient developed progressive ventricular outflow tract obstruction requiring surgical resection, whereas the other demonstrated stable disease with subsequent development of nonischemic cardiomyopathy managed medically. These cases underscore the incremental value of CMR in detecting, characterizing, and monitoring myocardial metastases. Integration of positron emission tomography and CMR may enable earlier diagnosis and inform management decisions. A multidisciplinary approach is essential, as selected patients may benefit from surgical or systemic therapies despite the typically indolent course of cardiac NET metastases.

Indexed as

cardiac magnetic resonanceechocardiographynuclear medicine

Identifiers

PMID42153926
PMCPMC13326188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.